DEC 27, 2016 6:52 PM PST

New Experimental Drug To Mend Heart Failure

WRITTEN BY: Kara Marker

Cimaglermin, a new drug under investigation, could be the future of cardiovascular medicine. A new study from scientists at Vanderbilt show the possibility of the drug for the restoration of cardiac function after heart failure, a leading cause of death for Americans.

Source: www.abouthf.org

More often than not, heart failure patients with severe left ventricular systolic dysfunction in particular do not respond well to current methods of treatment, which led researchers to cimaglermin as an alternative.

Led by Vanderbilt’s Daniel L. Lenihan, MD, researchers conducted a study with 40 heart failure patients who had all been receiving optimal medical therapy post-heart failure for at least three months before they entered the trial and began receiving cimaglermin. However, the researchers only examined the effects on safety and efficacy for a single dose of cimaglermin.

Compared to control participants who were just given a placebo, participants who received the single infusion of cimaglermin showed a substantial increase in pumping capacity, measured in terms of left ventricular ejection fraction. While still an experimental drug, cimaglermin was already being shown to boost the natural mechanisms for repairing all aspects of heart: structural, metabolic, and contractile elements.

“Instead of blocking the fundamental mechanisms that lead to cardiac injury, the early results with cimaglermin suggest that it may also be possible to administer therapeutics that allow the failing heart to repair itself using its own repair mechanisms,” explained Douglas L. Mann, MD, FACC, editer-in-chief of JACC: Back to Translational Science. The current study showed that the most common side effects of the drug were nausea and headaches.

“As with all experimental therapeutics, additional studies will be required and subject to regulatory review to determine if the relative risks and benefits of cimaglermin warrant approval,” said Lenihan. Studies will continue with more participants and more doses of the drug.

Lenihan’s study was recently published in the journal JACC: Basic to Translational Science.

Sources: Vanderbilt University, American College of Cardiology

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 28, 2020
Cardiology
Looking to Newborns for Help Healing Scars on the Heart
JUL 28, 2020
Looking to Newborns for Help Healing Scars on the Heart
Scars are a badge of honor to many, but they are really just a consequence of the body’s repair response. The body ...
AUG 13, 2020
Cardiology
Using Artificial Intelligence to Read Your ECG Results
AUG 13, 2020
Using Artificial Intelligence to Read Your ECG Results
An electrocardiogram (ECG) is a tool used to measure the heartbeat using an electrical current. By following the current ...
AUG 27, 2020
Immunology
A Seaweed-Inspired Shuttle for Delivering a Stem Cell Cargo
AUG 27, 2020
A Seaweed-Inspired Shuttle for Delivering a Stem Cell Cargo
  Living medicines in the form of stem cell therapies have immense potential for their ability to regenerate and he ...
SEP 01, 2020
Cardiology
Can the Protein Dysferlin Protect Your Heart from Reperfusion Injury
SEP 01, 2020
Can the Protein Dysferlin Protect Your Heart from Reperfusion Injury
Have you ever experienced the head rush you get from standing up to fast? Well, oddly enough, something similar happens ...
SEP 03, 2020
Cardiology
Does Hypertension Make It Harder to Recognize Others Emotions?
SEP 03, 2020
Does Hypertension Make It Harder to Recognize Others Emotions?
Have you ever felt your blood pressure rise when you get angry or stressed? Well, this phenomenon is unique in that it l ...
OCT 29, 2020
Cardiology
Treating Cardiovascular Calcification at the Source
OCT 29, 2020
Treating Cardiovascular Calcification at the Source
The term cardiovascular disease covers a broad array of health problems. Everyone tends to think of heart attacks or hyp ...
Loading Comments...